Compared with free EPA, EPA nanovesicles maintain higher stability in the circulatory system, accumulate and release at tumor sites through clathrin-mediated endocytosis, and enhance IDO1 inhibition and T cell proliferation. This evidence concerns the gene IDO1 and neoplasm.